Alhambra Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
ATO
CGH
Alhambra Investment Management's GILD Position: Q2 2026 in Review
Alhambra Investment Management increased its Gilead Sciences (GILD) stake by 11% in Q2 2026, buying an estimated $27.5K and bringing the position to 2,067 shares worth $261K. The position accounts for 0.11% of the portfolio, ranked #146.
Alhambra Investment Management first reported a position in GILD in Q4 2022 and has held it in 8 quarters since. 837 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Alhambra Investment Management held 2,067 shares of Gilead Sciences worth $261K as of Q2 2026.
- Alhambra Investment Management bought 209 Gilead Sciences shares in Q2 2026, an estimated $27.5K.
- Gilead Sciences made up 0.11% of Alhambra Investment Management's portfolio in Q2 2026, its #146 holding.
- Alhambra Investment Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 8 quarters since.
- 837 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Alhambra Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.